190 related articles for article (PubMed ID: 31090329)
1. [Aconitine ameliorates cardiomyocyte hypertrophy induced by angiotensin Ⅱ].
Wang NN; Wang J; Tan HL; Wang YG; Gao Y; Ma ZC
Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(8):1642-1647. PubMed ID: 31090329
[TBL] [Abstract][Full Text] [Related]
2. GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice.
Zhang C; Wang Y; Ge Z; Lin J; Liu J; Yuan X; Lin Z
Curr Mol Med; 2018; 18(10):661-671. PubMed ID: 30714521
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
[TBL] [Abstract][Full Text] [Related]
4. Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.
Yin Z; Wang X; Zhang L; Zhou H; Wei L; Dong X
Cardiovasc Ther; 2016 Feb; 34(1):21-9. PubMed ID: 26506219
[TBL] [Abstract][Full Text] [Related]
5. [Effect and mechanism of Linggui Zhugan Decoction in regulating Sig1R on AngⅡ-induced cardiomyocyte hypertrophy].
Wang X; Mo JJ; Tang TJ; Ding R; Huang JL
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(3):754-762. PubMed ID: 38621879
[TBL] [Abstract][Full Text] [Related]
6. The Effects of Dracocephalum Heterophyllum Benth Flavonoid on Hypertrophic Cardiomyocytes Induced by Angiotensin II in Rats.
Jiang H; Zhang C; He W
Med Sci Monit; 2018 Sep; 24():6322-6330. PubMed ID: 30199522
[TBL] [Abstract][Full Text] [Related]
7. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
[TBL] [Abstract][Full Text] [Related]
8. VEGFB-VEGFR1 ameliorates Ang II-induced cardiomyocyte hypertrophy through Ca
Shen Z; Zhang Z; Wang X; Yang K
J Cell Biochem; 2018 Feb; 119(2):1511-1520. PubMed ID: 28771828
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention.
Tu Y; Wan L; Bu L; Zhao D; Dong D; Huang T; Cheng Z; Shen B
Cell Physiol Biochem; 2013; 31(6):997-1008. PubMed ID: 23860036
[TBL] [Abstract][Full Text] [Related]
10. 3,3'-Diindolylmethane attenuates cardiac H9c2 cell hypertrophy through 5'-adenosine monophosphate-activated protein kinase-α.
Zong J; Wu QQ; Zhou H; Zhang JY; Yuan Y; Bian ZY; Deng W; Dai J; Li FF; Xu M; Fang Y; Tang QZ
Mol Med Rep; 2015 Jul; 12(1):1247-52. PubMed ID: 25816057
[TBL] [Abstract][Full Text] [Related]
11. An adenosine A1 agonist 2-chloro-N6 cyclopentyladenosine inhibits the angiotensin II-induced cardiomyocyte hypertrophy through the calcineurin pathway.
Zhang X; Xia J; Qian D; Wang Y; Lin Y; Huang X; Tan J
Cardiology; 2014; 129(3):153-62. PubMed ID: 25277512
[TBL] [Abstract][Full Text] [Related]
12. G-protein coupled receptor 30 attenuates myocardial hypertrophy by reducing oxidative stress and apoptosis in Ang II-treated mice.
Wang Y; Xing Y; Liu X; Chen L; Zhang G; Li Y
Peptides; 2022 Nov; 157():170878. PubMed ID: 36108979
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of lncRNA MALAT1 Inhibits Angiotensin II-induced Hypertrophic Effects of Cardiomyocytes by Regulating SIRT4 via miR-93-5p.
Ji H; Qu J; Peng W; Yang L
Int Heart J; 2022; 63(3):602-611. PubMed ID: 35650160
[TBL] [Abstract][Full Text] [Related]
14. Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway.
Tan X; Li J; Wang X; Chen N; Cai B; Wang G; Shan H; Dong D; Liu Y; Li X; Yang F; Li X; Zhang P; Li X; Yang B; Lu Y
Int J Biol Sci; 2011 Apr; 7(3):383-9. PubMed ID: 21494433
[TBL] [Abstract][Full Text] [Related]
15. Effects of Sirt3‑autophagy and resveratrol activation on myocardial hypertrophy and energy metabolism.
Wang HN; Li JL; Xu T; Yao HQ; Chen GH; Hu J
Mol Med Rep; 2020 Aug; 22(2):1342-1350. PubMed ID: 32468001
[TBL] [Abstract][Full Text] [Related]
16. Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes.
Harada M; Itoh H; Nakagawa O; Ogawa Y; Miyamoto Y; Kuwahara K; Ogawa E; Igaki T; Yamashita J; Masuda I; Yoshimasa T; Tanaka I; Saito Y; Nakao K
Circulation; 1997 Nov; 96(10):3737-44. PubMed ID: 9396478
[TBL] [Abstract][Full Text] [Related]
17. Ginkgolide B Protects Cardiomyocytes from Angiotensin II-Induced Hypertrophy via Regulation of Autophagy through SIRT1-FoxO1.
Jiang Q; Lu M; Li J; Zhu Z
Cardiovasc Ther; 2021; 2021():5554569. PubMed ID: 34257705
[TBL] [Abstract][Full Text] [Related]
18. Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathway.
Li X; Lan Y; Wang Y; Nie M; Lu Y; Zhao E
Mol Med Rep; 2017 May; 15(5):2574-2582. PubMed ID: 28447738
[TBL] [Abstract][Full Text] [Related]
19. Let-7a Is an Antihypertrophic Regulator in the Heart via Targeting Calmodulin.
Zhou X; Sun F; Luo S; Zhao W; Yang T; Zhang G; Gao M; Lu R; Shu Y; Mu W; Zhuang Y; Ding F; Xu C; Lu Y
Int J Biol Sci; 2017; 13(1):22-31. PubMed ID: 28123343
[No Abstract] [Full Text] [Related]
20. Role of microRNA-124 in cardiomyocyte hypertrophy inducedby angiotensin II.
Bao Q; Chen L; Li J; Zhao M; Wu S; Wu W; Liu X
Cell Mol Biol (Noisy-le-grand); 2017 Apr; 63(4):23-27. PubMed ID: 28478799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
